TNXP
Tonix Pharmaceuticals Holding Corp
NASDAQ: TNXP · HEALTHCARE · BIOTECHNOLOGY
$12.93
+4.27% today
Updated 2026-04-30
Market cap
$179.13M
P/E ratio
—
P/S ratio
13.67x
EPS (TTM)
$-14.57
Dividend yield
—
52W range
$12 – $70
Volume
0.4M
Tonix Pharmaceuticals Holding Corp (TNXP) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0.00 | $1875.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.91M | $0.00 | $9.03M | $7.77M | $10.09M | $13.11M |
| Revenue growth (YoY) | — | — | — | — | — | -100.0% | — | — | — | — | — | — | — | -100.0% | — | -13.9% | +29.9% | +29.8% |
| Cost of revenue | $7111.00 | $17000.00 | — | $3.38M | $6.66M | $10.89M | $27.66M | $48.16M | $38.97M | $21.29M | $26.32M | $28.83M | $50.51M | $92.31M | $112.09M | $4.74M | $7.76M | $6.64M |
| Gross profit | $-7111.00 | $-17000.00 | — | $-3.38M | $-6.66M | $-10.89M | $-27.66M | $-48.16M | $-38.97M | $-21.29M | $-26.32M | $-28.83M | $-50.51M | $-92.31M | $-112.09M | $3.03M | $2.33M | $6.47M |
| Gross margin | — | — | — | — | -355275.2% | — | — | — | — | — | — | — | -1733.4% | — | -1241.7% | 39.0% | 23.1% | 49.3% |
| R&D | — | — | — | $1.16M | $2.58M | $4.65M | $18.62M | $35.50M | $28.53M | $13.34M | $17.56M | $18.19M | $36.16M | $68.84M | $81.88M | $86.66M | $40.45M | $44.49M |
| SG&A | $14023.00 | $13866.00 | $13724.00 | $2.22M | $4.08M | $6.24M | $9.04M | $12.66M | $10.44M | $7.95M | $8.76M | $10.64M | $14.35M | $23.47M | $30.21M | $34.75M | $3.40M | $87.68M |
| Operating income | $-21134.00 | $-30866.00 | $-17724.00 | $-3.38M | $-6.66M | $-10.89M | $-27.66M | $-48.16M | $-38.97M | $-21.29M | $-26.32M | $-28.83M | $-50.51M | $-92.31M | $-112.09M | $-118.38M | $-136.70M | $-125.70M |
| Operating margin | — | — | — | — | -355275.2% | — | — | — | — | — | — | — | -1733.4% | — | -1241.7% | -1523.9% | -1354.3% | -959.1% |
| EBITDA | $-21134.00 | $-30866.00 | $-17724.00 | $-3.37M | $-6.65M | $-10.87M | $-27.62M | $-48.00M | $-38.76M | $-21.22M | $-26.27M | $-28.80M | $-50.48M | $-92.26M | $-110.84M | $-114.09M | $-74.32M | $-123.78M |
| EBITDA margin | — | — | — | — | -354411.0% | — | — | — | — | — | — | — | -1732.5% | — | -1227.8% | -1468.7% | -736.3% | -944.4% |
| EBIT | $-21134.00 | $-30866.00 | $-17724.00 | $-3.38M | $-6.66M | $-10.89M | $-27.66M | $-48.16M | $-38.97M | $-21.29M | $-26.32M | $-28.83M | $-50.51M | $-92.31M | $-112.09M | $-118.38M | $-77.74M | $-125.70M |
| Interest expense | $0.00 | $0.00 | $0.00 | $91585.00 | $1.61M | $4000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $50000.00 | $7.91M | — | $1.23M | $88999.00 |
| Income tax | $21134.00 | $30866.00 | $17724.00 | $3.38M | $1.61M | $-17000.00 | $-36000.00 | $-161000.00 | $-206000.00 | $-70000.00 | $233000.00 | $-236000.00 | $-75000.00 | $-75000.00 | $4.79M | $-1.00 | $-1.17M | — |
| Effective tax rate | — | — | — | -3689.0% | 100.6% | 0.2% | 0.1% | 0.3% | 0.5% | 0.3% | -0.9% | 0.8% | 0.1% | 0.1% | -4.3% | 0.0% | 0.9% | 0.0% |
| Net income | $-21134.00 | $-30866.00 | $-17724.00 | $-3.47M | $-9450.00 | $-10.88M | $-27.62M | $-48.05M | $-38.84M | $-21.12M | $-26.09M | $-28.38M | $-50.39M | $-92.21M | $-115.00M | $-116.66M | $-130.04M | $-124.02M |
| Net income growth (YoY) | — | -46.0% | +42.6% | -19478.6% | +99.7% | -115074.6% | -153.7% | -74.0% | +19.2% | +45.6% | -23.5% | -8.8% | -77.5% | -83.0% | -24.7% | -1.4% | -11.5% | +4.6% |
| Profit margin | — | — | — | — | -504.0% | — | — | — | — | — | — | — | -1729.2% | — | -1274.0% | -1501.8% | -1288.3% | -946.2% |